Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...

Padcev, an antibody-drug conjugate which Pfizer acquired via its $43 billion Seagen deal, could help people who don’t qualify ...

Merck & Co., Inc. (NYSE:MRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Merck & Co., Inc. (NYSE:MRK) has ...

Merck MRK announced mixed second-quarter results last month. The company beat estimates for earnings while meeting the same ...

Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

The multiyear effort comes as Merck prepares to offset revenue losses from the upcoming patent expiration of its blockbuster ...

IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...